Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | 14,75 € | 24,13 € | 63,67 % |
| Verastem Inc. | 9 | 0 | 1 | 0 | 3,76 € | 24,63 € | 555,18 % |
| Xeris Biopharma Holdings Inc. | 5 | 0 | 1 | 0 | 1,80 € | 4,16 € | 131,18 % |
| Abbott Laboratories | 17 | 0 | 1 | 0 | 95,81 € | 116,71 € | 21,82 % |
| Cigna Corp. | 16 | 0 | 2 | 0 | 306,55 € | 342,35 € | 11,68 % |
| Vertex Pharmaceuticals Inc. | 46 | 2 | 6 | 0 | 421,20 € | 423,03 € | 0,43 % |
| Myriad Genetics | 5 | 2 | 1 | 0 | 21,40 € | 25,14 € | 17,50 % |
| US Physical Therapy Inc. | 8 | 1 | 1 | 0 | 94,50 € | 109,94 € | 16,34 % |
| Dynavax Technologies Corp | 2 | 0 | 1 | 0 | 10,96 € | 26,95 € | 145,89 % |
| Edwards Lifesciences Corp. | 27 | 1 | 4 | 0 | 81,08 € | 88,17 € | 8,74 % |
| Cytokinetics Inc. | 31 | 1 | 8 | 0 | 44,60 € | 83,13 € | 86,39 % |
| Halozyme Therapeutics Inc. | 15 | 0 | 3 | 0 | 40,40 € | 47,17 € | 16,76 % |
| Brookdale Sr Lvg | 2 | 0 | 0 | 0 | 6,20 € | 8,27 € | 33,43 % |
| Insulet Corp. | 16 | 0 | 2 | 0 | 166,05 € | 215,54 € | 29,80 % |
| Masimo Corp. | 7 | 1 | 1 | 0 | 117,05 € | 147,62 € | 26,11 % |
| EyePoint Pharmaceuticals Inc. | 18 | 1 | 4 | 0 | 10,28 € | 27,80 € | 170,47 % |
| Codexis Inc. | 5 | 2 | 1 | 0 | 3,23 € | 8,36 € | 158,67 % |
| Agios Pharmaceuticals Inc. | 6 | 0 | 1 | 0 | 31,40 € | 38,99 € | 24,17 % |
| Radnet Inc. | 9 | 3 | 2 | 0 | 54,00 € | 54,58 € | 1,08 % |
| Cara Therapeutics Inc. | 11 | 1 | 3 | 0 | 0,68 € | 4,62 € | 580,56 % |
| Intra-Cellular Therapies Inc. | 25 | 0 | 2 | 0 | 60,50 € | 79,55 € | 31,49 % |
| Akebia Therapeutics Inc. | 8 | 2 | 0 | 0 | 1,02 € | 3,64 € | 257,64 % |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 1 | 0 | 37,40 € | 84,74 € | 126,59 % |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | 3,50 € | - | - |
| Abeona Therapeutics Inc. | 4 | 1 | 1 | 0 | 3,76 € | 33,73 € | 797,03 % |